Insider sale
TERNS PHARMACEUTICALS, INC.
$2.28M
348.86K shares
What this filing means
VIVO OPPORTUNITY FUND HOLDINGS, L.P. plans to sell 348.86K shares of TERNS PHARMACEUTICALS, INC. valued at approximately $2.28M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/3/2024ACC: 0000048966-24-000009
10% Owner
Since Aug 2022
348.86K
Shares to sell
$2.28M
Approx. market value
136.26K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
IPO Allocation
Cash
2/4/2021
136.26KTotal acquired136.26K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/4/2021 | IPO Allocation Cash | 136.26K | — |
| Total | 136.26K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
76.35K
Market value
$507.6K
4/2/2024
—Completed
Units to sell
136.25K
Market value
$953.3K
4/1/2024
Planned — Approximate Date
NasdaqPlanned
Units to sell
136.26K
Market value
$817.5K
4/3/2024
Total
Units
348.86K
Value
$2.28M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/2/2024 | 76.35K | $507.6K | — | Completed |
4/1/2024 | 136.25K | $953.3K | — | Completed |
| Planned — Approximate Date | ||||
4/3/2024 | 136.26K | $817.5K | Nasdaq | Planned |
| Total | 348.86K | $2.28M | ||